Jaleva Pharmaceuticals
San Diego
About Jaleva Pharmaceuticals
Jaleva Pharmaceuticals, LLC, a specialty pharmaceutical company, engages in the research and development of dermal drug delivery system that promotes transmucosal and topical delivery of medications for central nervous system markets. Its products include Mast-R-Prep, a chlorhexidine-based surgical skin prep product; and Stayzon, an antibiotic surgical adhesive. The company’s formulations are designed to provide delivery of alprazolam for anxiety; ondansetron for nausea; sumitriptan for migraines; fentanyl for pain; and nicotine as an aid to smoking cessation. Jaleva Pharmaceuticals, LLC was founded in 1999 and is based in San Diego, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $454.5K
- Last round: Series Unknown (May 2011)
- Website: jaleva.com
- Phone: 561-573-0094
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/jaleva-pharmaceuticals-2693741 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.